The current study was undertaken to evaluate the prevalence of NPM1 mutations in childhood AML in association with cytogenetic analysis, molecular screening of common gene mutations and patients' clinical characteristics, in order to address its prognostic relevance. The gene discussed is NPM1; the disease is acute myeloid leukemia.